|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-2-3
|
|
pubmed:abstractText |
Poor tolerance and adverse drug reactions are main reasons for discontinuation of antiretroviral therapy (ART). Identifying predictors of ART discontinuation is a priority in HIV care.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1537-6613
|
|
pubmed:author |
pubmed-author:BernasconiEnosE,
pubmed-author:CavassiniMatthiasM,
pubmed-author:ColomboSaraS,
pubmed-author:ElziLuigiaL,
pubmed-author:FurrerHansjakobH,
pubmed-author:GünthardHuldrych FHF,
pubmed-author:HirschelBernardB,
pubmed-author:LedergerberBrunoB,
pubmed-author:LubomirovRubinR,
pubmed-author:MartinezRaquelR,
pubmed-author:Swiss HIV Cohort Study,
pubmed-author:TelentiAmalioA,
pubmed-author:VernazzaPietroP,
pubmed-author:di IulioJuliaJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
203
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
246-57
|
|
pubmed:dateRevised |
2011-4-6
|
|
pubmed:meshHeading |
pubmed-meshheading:21288825-Adult,
pubmed-meshheading:21288825-Anti-HIV Agents,
pubmed-meshheading:21288825-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:21288825-Cohort Studies,
pubmed-meshheading:21288825-Female,
pubmed-meshheading:21288825-Genetic Markers,
pubmed-meshheading:21288825-HIV Infections,
pubmed-meshheading:21288825-Humans,
pubmed-meshheading:21288825-Male,
pubmed-meshheading:21288825-Medication Adherence,
pubmed-meshheading:21288825-Middle Aged,
pubmed-meshheading:21288825-Pharmacogenetics
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study.
|
|
pubmed:affiliation |
Institute of Microbiology, University Hospital of Lausanne, 1011 Lausanne, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
